Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-angiogenic nano-delivery system promotes tumor vascular normalizing and micro-environment reprogramming in solid tumor
Ruoyu Shen, Lijun Peng, Wentao Zhou, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 550-564
Closed Access | Times Cited: 23

Showing 23 citing articles:

Developing a Copper(II) Isopropyl 2-Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin–Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment
Xueyu Man, Shanhe Li, Gang Xu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5744-5757
Closed Access | Times Cited: 16
Optimized strategies of ROS-based nanodynamic therapies for tumor theranostics
Yifan Di, Ruizhu Deng, Zhu Liu, et al.
Biomaterials (2023) Vol. 303, pp. 122391-122391
Closed Access | Times Cited: 35
Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Yi Pan, Longcai Liu, Xiaozhou Mou, et al.
ACS Nano (2023) Vol. 17, Iss. 21, pp. 20875-20924
Closed Access | Times Cited: 26
Natural-product-based, carrier-free, noncovalent nanoparticles for tumor chemo-photodynamic combination therapy
Zhonglei Wang, Liyan Yang
Pharmacological Research (2024) Vol. 203, pp. 107150-107150
Open Access | Times Cited: 13
The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 11
Ultrasound‐mediated nano‐sized drug delivery systems for cancer treatment: Multi‐scale and multi‐physics computational modeling
Farshad Moradi Kashkooli, Tyler K. Hornsby, Michael C. Kolios, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 19
Emerging nanotechnological approaches to regulating tumor vasculature for cancer therapy
Chunling Wang, Junchao Xu, Yinlong Zhang, et al.
Journal of Controlled Release (2023) Vol. 362, pp. 647-666
Closed Access | Times Cited: 18
Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers
Xumei Ouyang, Yu Liu, Ke Zheng, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 19, Iss. 1, pp. 100883-100883
Open Access | Times Cited: 14
Immunotherapies targeting tumor vasculature: challenges and opportunities
Hassan Dianat‐Moghadam, Reza Nedaeinia, Mohsen Keshavarz, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Targeting tumor angiogenesis and metabolism with photodynamic nanomedicine
Yong Lv, Lihui Pu, Bei Ran, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Application of nanoparticles to target tumor blood vessels as a promising cancer treatment strategy
Patryk Lorenc, Hanna Dams-Kozłowska, Natalia Guzniczak, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118038-118038
Closed Access
Combating cancer immunotherapy resistance: a nano‐medicine perspective
Xiangyi Kong, Xintong Xie, Juan Wu, et al.
Cancer Communications (2025)
Open Access
Multi salt strategy based on curcumin pyrimidine derivatives prodrugs: Synthesis, biological activity, in vitro and in vivo imaging, and drug distribution research
Guangchang Lian, Ying Liu, Kaibo Hu, et al.
Dyes and Pigments (2023) Vol. 216, pp. 111310-111310
Closed Access | Times Cited: 11
Disulfiram-loaded CuO2 nanocarriers for enhanced synergistic chemodynamic chemotherapy
Wei Hu, Lianlian Yang, Hongtao Liao, et al.
Journal of Colloid and Interface Science (2024) Vol. 674, pp. 9-18
Closed Access | Times Cited: 4
DH5α Outer Membrane‐Coated Biomimetic Nanocapsules Deliver Drugs to Brain Metastases but not Normal Brain Cells via Targeting GRP94
Mengyuan Zhou, Haiyan Chen, Yuteng Zeng, et al.
Small (2023) Vol. 19, Iss. 35
Closed Access | Times Cited: 10
The potential of vascular normalization for sensitization to radiotherapy
Zhili Guo, Lingling Lei, Zenan Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32598-e32598
Open Access | Times Cited: 2
Smart anti-vascular nanoagent induces positive feedback loop for self-augmented tumor accumulation
Mengting Du, Tingting Geng, Rongrong Yu, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 595-609
Closed Access | Times Cited: 5
Heterocyclic Molecular Targeted Drugs and Nanomedicines for Cancer: Recent Advances and Challenges
Junxia Liu, Tengfei Chao, Yingying Liu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1706-1706
Open Access | Times Cited: 5
Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment
Saade Abdalkareem Jasim, I.M. Farber, Sara Abdalrazzaq M. Noraldeen, et al.
Microvascular Research (2024) Vol. 154, pp. 104691-104691
Closed Access | Times Cited: 1
Biologically based strategies for overcoming in vivo barriers with functional nano‐delivery systems
Roya Ahmadzadeh, Seyed Alireza Taheri, Neda Mohammadi, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 8
Closed Access | Times Cited: 1
“Targeted plus controlled” – Composite nano delivery system opens the tumor vascular and microenvironment normalization window for anti-tumor therapy
Ruoyu Shen, Qi Jiang, Pei‐Rong Li, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123512-123512
Closed Access | Times Cited: 3
Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges
Jie Xu, Yaomei Tian, Die Hu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 3
Open Access
iRGD-mediated liposomal nanoplatforms for improving hepatocellular carcinoma targeted combination immunotherapy and monitoring tumor response via IVIM-MRI
Jiamin Li, Ruili Wei, Yao Wang, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 39, pp. 9963-9978
Closed Access
Dual-phase nanoscissors disrupt vasculature-breast cancer stem cell crosstalk for breast cancer treatment
Qi Yao, Shuai Lv, Changheng Xie, et al.
Journal of Controlled Release (2024) Vol. 377, pp. 781-793
Closed Access
Polymer-Modified Lipid Nanoparticles with Microenvironment-Responsive Graded Release for Amplified Photodynamic Therapy Through Tumor Vascular Normalization
Ruoyu Shen, Pei‐Rong Li, Ding Wang, et al.
ACS Applied Nano Materials (2023) Vol. 6, Iss. 14, pp. 13352-13362
Closed Access | Times Cited: 1
Page 1

Scroll to top